John WeeksThe advancing comparative effectiveness research (CER) agenda of the Obama era has been linked to complementary and alternative medicine (CAM) since the IOM weighed in on the topic in June 2009. The health reform law specifically included...
In this section of a two-part series, Integrator contributor Daphne White, CHTP focuses on the political-economic dynamics behind the $1.1 billion "clinical effectiveness research" (CER) initiative. White examines what she calls the "Kabuki play" ...
